Feedback
Settings

Settings

Goto Application

1. WO2022093818 - OCULAR IMPLANT CONTAINING AN ACTIVE AGENT

Submit observation
PermaLink
Publication Number WO/2022/093818
Publication Date 05.05.2022
International Application No. PCT/US2021/056648
International Filing Date 26.10.2021
IPC
A61K 31/436 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
435having six-membered rings with one nitrogen as the only ring hetero atom
4353ortho- or peri-condensed with heterocyclic ring systems
436the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
A61K 31/44 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
435having six-membered rings with one nitrogen as the only ring hetero atom
44Non-condensed pyridines; Hydrogenated derivatives thereof
A61P 27/02 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
27Drugs for disorders of the senses
02Ophthalmic agents
C08L 71/00 2006.1
CCHEMISTRY; METALLURGY
08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
71Compositions of polyethers obtained by reactions forming an ether link in the main chain; Compositions of derivatives of such polymers
C08L 71/02 2006.1
CCHEMISTRY; METALLURGY
08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
71Compositions of polyethers obtained by reactions forming an ether link in the main chain; Compositions of derivatives of such polymers
02Polyalkylene oxides
Applicants
  • OCULAR THERAPEUTIX, INC. [US]/[US]
Inventors
  • BLIZZARD, Charles, D.
  • DRISCOLL, Arthur
  • EL-HAYEK, Rami
  • GOLDSTEIN, Michael
  • IACONA, Joseph
  • JARRETT, Peter
  • JARRETT, Timothy, S.
  • KAHN, Erica
  • LATTRELL, Zachary
Agents
  • PARADISO, Robert, J.
  • KESSLEN, Mark, P.
  • SIERCHIO, Daniel, D.
  • TOMA, David
  • PORTNOVA, Marina
Priority Data
63/106,27027.10.2020US
63/165,42324.03.2021US
63/209,72511.06.2021US
Publication Language English (en)
Filing Language English (EN)
Designated States
Title
(EN) OCULAR IMPLANT CONTAINING AN ACTIVE AGENT
(FR) IMPLANT OCULAIRE CONTENANT UN PRINCIPE ACTIF
front page image
Abstract
(EN) The invention relates to a sustained release biodegradable ocular implant containing a tyrosine kinase inhibitor dispersed in a hydrogel for the treatment of a retinal disease for an extended period of time.
(FR) L'invention concerne un implant oculaire biodégradable à libération prolongée contenant un inhibiteur de tyrosine kinase dispersé dans un hydrogel pour le traitement d'une maladie rétinienne pendant une période de temps prolongée.
Latest bibliographic data on file with the International Bureau
# -